ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications

March 4, 1983

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000